Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-POLR2A Antibody (R3G62)

Catalog #:   RHD64607 Specific References (13) DATASHEET
Host species: Mouse
Isotype: IgG2b
Applications: ELISA, FCM
Accession: P24928
Overview

Catalog No.

RHD64607

Species reactivity

Human

Host species

Mouse

Isotype

IgG2b

Clonality

Monoclonal

Tested applications

ELISA: 1:10000, FCM: 1:200-1:400

Target

DNA-directed RNA polymerase II subunit A, RNA-directed RNA polymerase II subunit RPB1, RNA polymerase II subunit B1, POLR2A, POLR2, DNA-directed RNA polymerase II subunit RPB1, DNA-directed RNA polymerase III largest subunit

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P24928

Applications

ELISA, FCM

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% Sodium Azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

R3G62

Data Image
  • Flow Cytometry
    Flow cytometric analysis of Hela cells using POLR2A mouse mAb (green) and negative control (red).
References

Genetic determinants of proteomic aging., PMID:40287427

Reliable detection of RNA in hippocampus sections of mice by FISH up to a post-mortem delay of 24 h., PMID:38582805

Novel Anti-B-cell Maturation Antigen Alpha-Amanitin Antibody-drug Conjugate HDP-101 Shows Superior Activity to Belantamab Mafodotin and Enhanced Efficacy in Deletion 17p Myeloma Models., PMID:38260385

Combined Wee1 and EGFR inhibition reveals synergistic antitumor effect in esophageal squamous cell carcinoma., PMID:37279554

Targeted immunotherapy for HER2-low breast cancer with 17p loss., PMID:33568521

Quantitative analysis of HER2 mRNA expression by RNA in situ hybridization in canine mammary gland tumors: Comparison with immunohistochemistry analysis., PMID:32059046

Novel Antibody-Drug Conjugate with Anti-CD26 Humanized Monoclonal Antibody and Transcription Factor IIH (TFIIH) Inhibitor, Triptolide, Inhibits Tumor Growth via Impairing mRNA Synthesis., PMID:31398954

BRAF inhibition sensitizes melanoma cells to α-amanitin via decreased RNA polymerase II assembly., PMID:31123282

Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II., PMID:30349055

RNAscope in situ hybridization confirms mRNA integrity in formalin-fixed, paraffin-embedded cancer tissue samples., PMID:29212158

TP53 loss creates therapeutic vulnerability in colorectal cancer., PMID:25901683

Nuclear localization of CD26 induced by a humanized monoclonal antibody inhibits tumor cell growth by modulating of POLR2A transcription., PMID:23638030

Using ChIP-chip technology to reveal common principles of transcriptional repression in normal and cancer cells., PMID:18347325

Datasheet

Document Download

Anti-POLR2A Antibody (R3G62).pdf

 

$ 220
Product specifications
50 μg 220 100 μg 350

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-POLR2A Antibody (R3G62) [RHD64607]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only